The Middle EAST Blood-Brain Barrier (BBB) Market was valued at USD 0.45 billion in 2024 and is projected to reach USD 1.20 billion by 2034, registering a CAGR of 9.8%. This growth trajectory is underpinned by several factors, including the rising prevalence of neurological disorders, advancements in drug delivery systems, and an increasing focus on research and development in the pharmaceutical...